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I. INTRODUCTION 
The study of brucellosis in cattle, leading to the eventual eradica-
tion of the disease, is of importance from both public health and economic 
aspects (1). Since brucellosis is not generally transmitted from person 
to person, the prevention of human infection depends upon the control and 
elimination of the disease in animals (2). 
Brucella are small aerobic gram-negative rods or coccobacilli. These 
facultative intracellular parasites are devoid of capsules, flagella, 
spores, and exotoxins. When brucellae are introduced into skin, polymorpho-
nuclear leukocytes (PMNS) are mobilized within hours and phagocytosis 
occurs (3). 
The PMN is produced in the bone marrow from a common ancestral stem 
cell (4). The primary function of the PMN is ingestion and digestion of 
microorganisms in tissues of the host animal (5). For the PMN to ingest 
the microorganism it must first migrate to the infection site. A variety 
of soluble factors and other components, including lymphokines, released 
at the site of infection attract PMNS in a process called chemotaxis (6). 
Lymphokines are produced and released by lymphocytes. A lymphokine of 
importance in the in vitro leukocyte migration inhibition assay is the 
leukocyte migration inhibition factor (7). 
Leukocyte migration inhibition assays and lymphocyte blastogenesis are 
considered in vitro correlates of cell-mediated immune responsiveness. 
Leukocyte migration inhibition has been used as an indicator of cell-
mediated immune responses in humans (8, 9, 10), cattle (11, 12, 13, 14, 
15), chickens (16), and swine (17). There are few reports of the use of 
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leukocyte migration assays to evaluate cell-mediated responses of cattle ex-
posed to Brucella. Lee (13) and Azadegan et al. (14) examined the responses 
of calves vaccinated with B. abortus strain 19. Dorsey and Deyoe examined 
responses of heifers experimentally infected with B. abortus strain 2308 
(15). Lymphocyte blastogenesis has been used to evaluate the cell-mediated 
immune responses of cattle exposed to~· abortus (18, 19, 20). Kaneene et 
al. used lymphocyte blastogenesis to differentiate the responses of cattle 
vaccinated with B. abortus strain 19 from the responses of cattle infected 
with field strain~· abortus (20). No reports are available comparing the 
leukocyte migration responses of adult vaccinated cattle to the responses 
of experimentally infected cattle. In some geographic areas adult vaccina-
tion of cattle with B. abortus strain 19 is used as a means of controlling 
the spread of brucellosis, thereby causing difficulty in differentiating 
the responses of vaccinated cattle from the responses of infected cattle 
(21). 
The objectives of this study were to: 
1. Examine some variables affecting an agarose leukocyte 
migration inhibition assay. 
2. Examine the applicability of the assay for detecting and 
differentiating cellular responses of cattle following 
exposure to virulent ~· abortus strain 2308 or attenuated 
B. abortus strain 19. 
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II. LITERATURE REVIEW 
A. Brucella 
Brucella are small aerobic gram-negative rods or coccobacilli. These 
facultative intracellular parasites devoid of capsules, flagella, spores, 
and exotoxins infect a wide variety of animal species, including humans. 
Brucellosis is transmissible by ingestion, inhalation, and contact (1). 
The primary routes of infection are gastrointestinal (ingestion) and pene-
tration of skin or mucous membranes, including conjunctiva (1). 
When cattle are exposed to virulent strains of!· abortus, any of 
three consequences are possible: 1. Infection may fail to result from 
that exposure; 2. Infection may occur without resulting in clinical 
diseas·e; 3. Infection may result in clinical disease (22). The most 
readily recognized symptom of clinical disease in cattle is abortion. This 
is pertinent only when the infected animal is pregnant, and over 20% of 
pregnant cattle infected with B. abortus fail to abort (23). 
The ability of!· abortus to multiply in the host tissues apparently 
determines the appearance of clinical symptoms. The growth of virulent 
strains of !· abortus is stimulated by erythritol, a carbohydrate substance 
produced by the.uterus of cattle (24). The greatest concentration of 
erythritol occurs in the placenta and foetal fluids; this is associated 
with localization of infection in these tissues (25). 
The study of brucellosis in cattle, leading to the eventual eradica-
tion of the disease, is of importance from both public health and economic 
aspects (1). Since brucellosis is not generally transmitted from person to 
4 
person, the prevention of human infection depends upon the control and 
elimination of the disease in animals, such as cattle. The economic 
losses caused by bovine brucellosis in the U.S.A. have been estimated to 
be in the millions of dollars annually (2). 
B. Cellular Response in Host 
When Brucella are introduced into skin, polymorphonuclear leukocytes 
(PMNS) are mobilized within hours and phagocytosis occurs (3). There are 
four phases of infection: 1. An initial phase characterized by the early 
growth and multiplication of Brucella; 2. A bacteriocidal phase when acti-
vated PMNS and macrophages ingest and kill the Brucella; 3. A plateau 
phase characterized by the presence of relatively constant low numbers of 
bacteria; 4. The final phase occurs when either all the Brucella are 
killed or the animal dies (26). Chronic infection occurs when the plateau 
phase is extended and may be associated with the relative resistance of B. 
abortus to PMN and macrophage killing (27). Granulomatous lesions contain-
ing lymphocytes, epitheloid cells, multinucleated giant cells, and plasma 
cells may be formed (28). 
1. Polymorphonuclear leukocytes (PMNS) 
The PMN originates in the bone marrow from a common stem cell. The 
cell divisions in PMN maturation include: myeloblast, promyelocyte, meta-
myelocyte, band cell, and finally the mature PMN (4). The PMN is an end 
cell of myeloid differentiation and does not divide. 
The primary function of the PMN is ingestion and digestion of micro-
organisms in tissues of the host animal (5). For the PMN to kill these 
microorganisms it must first migrate to the site of infection. Molecular 
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agents released at the site of infection from microbial, cellular or 
humeral origins attract PMNS in a process called chemotaxis (6). Opsiniza-
tion of the particle with immunoglobulins and complement components may be 
required before the PMN can bind to and ingest the microorganism (6). 
The antimicrobial systems of the PMN can be divided into two broad 
groups: the oxygen-dependent systems and the oxygen-independent systems. 
The oxygen-dependent systems include: myeloperoxidase (29), hydrogen 
peroxide (30), superoxide ion (31), hydroxyl radical (32), and singlet 
oxygen (33). The oxygen-independent systems include: lowered cellular pH 
(34, 35), lysozyme (30), lactoferrin (36), and granular cationic proteins 
(37). The hexose monophosphate shunt enzymes are believed to be involved 
in the oxygen-dependent systems (38). It has been suggested that this 
energy pathway is not stimulated by the ingestion of~· abortus; therefore, 
the organism can survive because degranulation does not occur (39). 
2. Lymphocytes 
Lymphocytes develop from pluripotent hemopoietic stem cells found in 
bone marrow (40). The lymphoid cell may develop into either a T-lymphocyte 
(maturation is thymus dependent) or a B-lymphocyte (maturation is thymus 
independent and dependent on the bursa of Fabricius in birds or possibly 
its equivalent in other animals) (41). The T-lymphocyte is primarily 
associated with cell-mediated immunity because it is capable of reacting 
to antigen _either directly or indirectly through the recruitment and 
activation of various inflammatory cells (42). The B-lymphocyte is 
primarily associated with humeral immunity because it is capable of dif-
ferentiating into a plasma cell capable of producing immunoglobulin (43). 
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In vitro the two lymphocyte types are differentiated by the ability of 
T-lymphocytes to form rosettes with sheep red blood cells and by the pres-
ence of surface immunoglobulin on B-lymphocytes (44, 45). Peripheral blood 
lymphocytes from normal cattle consist of approximately 633 T-lymphocytes, 
113 B-lymphocytes, and 263 null cells (46); null cells lack the character-
istics of either mature T- or B-lymphocytes. 
A complex cooperation occurs between the inflammatory cells involved 
in the immune response. Many of these processes seem to be governed by 
specifically reactive T-lymphocytes which are capable of enhancing or 
suppressing the activities of B-lymphocytes, macrophages, PMNS, and non-
committed T-lymphocytes (7). 
The term "lymphokine" was used by Dumonde et al. in 1969 to include 
all biologically active non-antibody mediators generated after lymphocyte 
activation (47]. More recently, Bendtzen restricted the term to antigen-
nonspecific biologically active proteins produced by lymphoid cells (7). 
These mediators are classified according to their biological functions in 
vitro and their hypothesized roles in vivo (7, 47). 
Some lymphokines affect T- and B-lymphocytes; these include mitogenic 
factor (48), antibody inhibitory material (49), Type II interferon (SO), 
and a histamine-induced suppressor factor (51). Other lymphokines affect 
the behavior of other cells participating in the immune response, including 
macrophages (52), eosinophiles (53), platelets (54), and PMNS (55, 56, 57). 
A lymphokine of primary importance in the leukocyte migration inhibi-
tion assay is the leukocyte migration inhibitory factor (LIF) (7). The LIF 
appears to be produced by an interaction of T- and B-lymphocytes or by a 
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subpopulation of lymphocytes because neither T-lymphocytes nor B-lymphocytes 
alone or with monocytes produce the lymphokine. However when T- and B-
lymphocytes are mixed LIF is produced in abundance (58). LIF selectively 
inhibits the migration of PMNS; macrophage migration is not inhibited by 
LIF (55). LIF inhibition of PMNS is not species specific because guinea 
pig PMNS are susceptible to the action of human LIF (59). 
LIF produced in cattle has not been extensively physiochemically 
analyzed. Therefore, for .the purposes of this discussion the properties 
of human LIF will be described with the assumption that bovine LIF is 
similar. LIF has a molecular weight of 50,000 to 70,000 (60, 61). LIF is 
considered a protein because of its buoyant density in isopycnic centrifu-
gation studies, its susceptibility to chymotrypsin, and its resistance to 
neuraminidase (60). 0 LIF is stable when exposed to 50 C for 1 hour, but is 
destroyed when exposed to 80° C for 30 minutes; LIF is stable when treated 
for 30 minutes to a pH between 4 and 10, but partially destroyed at pH 3 
or 11 (62). LIF appears to be an esterase and a protease (51, 62, 63). 
LIF obtained from sensitized lymphocytes stimulated with an antigen or with 
Concanavalin A (a non-specific mitogen) have similar physiochemical and 
I 
immunochemical properties (55, 60, 64). 
Exposure of PMNS to LIF for 1 hour at 37° C appears to be sufficient 
to inhibit the motility of cells for the next 24 hours (7). A receptor 
mechanism of LIF-PMN interaction is indicated because only PMNS, not mono-
nuclear cells or erythrocytes, are capable of absorbing the migration in-
hibitory activity from LIF-rich supernatants (7). 
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c. Leukocyte Migration Inhibition Assays 
Leukocyte migration inhibition assays are considered in vitro corre-
lates of cell-mediated immune responses. Holst in 1922 observed that the 
migration of human blood leukocytes out of capillary tubes was sometimes 
inhibited by tuberculin (65). Later, Rich and Lewis demonstrated tuberculin-
induced migration inhibition of spleen and buffy coat explants from guinea 
pigs exhibiting delayed-type hypersensitivity to tuberculin (66). Leuko-
cyte migration inhibition has been used as an indicator of cell-mediated 
immune responses in humans (8, 9, 10), cattle (11, 12, 13, 14, 15), 
chickens (16), and swine (17). 
To study the migration of leukocytes, usually either capillary tubes or 
agarose plates are used (8, 67, 68, 69). In the capillary tube technique, 
peritoneal exudate cells or peripheral blood leukocytes are placed in glass 
capillary tubes. The tubes are placed horizontally in chambers containing 
cell culture media; during incubation the cells migrate out of the tubes 
and spread on the bottom of the chambers. In the agarose plate technique, 
petri dishes containing a mixture of agarose and cell culture media are 
used. Suspensions of peripheral blood leukocytes are placed in wells cut 
in agarose; during incubation the cells migrate out of the wells in the 
space between the agarose and the supporting dish (12). 
There are few reports of the use of leukocyte migration assays to 
study brucellosis in cattle. Lee (13) and Azadegan et al. (14) examined 
the responses of calves vaccinated with!· abortus strain 19. Dorsey and 
Deyoe examined experimental infection in heifers (15). There are no reports 
available comparing the leukocyte migration responses of adult vaccinated 
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cattle to the responses of experimentally infected cattle. Because in some 
geographic areas adult vaccination of cattle with B. abortus strain 19 is 
used as a means of controlling the spread of brucellosis, there is a problem 
of differentiating the responses of vaccinated cattle from the responses of 
cattle infected with B. abortus (21). 
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III. MATERIALS AND METHODS 
A. Blood Sample Collection 
Approximately 90 ml of peripheral blood were aseptically collected by 
jugular venapuncture and placed in 2 sterile silicone-treated 15 x 120 mm 
screw-cap tubes. The anticoagulant was a 50% concentrate of acid-citrate-
1 dextrose (ACD) at a 1:10 v/v ratio with the blood. The tubes were ro-
tated to prevent the blood from clotting and kept at 22-25° C. Coagulated 
samples were discarded. 
B. Harvesting Cells from Blood 
1. Polymorphonuclear leukocytes (PMNS) 
The PMN-rich suspension was prepared by the method described by Roth 
and Kaeberle (70). Approximately 80 ml of whole blood containing ACD were 
centrifuged for 20 minutes at 1000 x g. The plasma layer, huffy coat, and 
a few ml of red blood cells were aseptically removed by aspiration. The 
erythrocytes were lysed by aseptically diluting them 2:1 with sterile 
phosphate buffered (0.01 M) triple distilled water (pH 7.4, 22-25° C) in an 
Erlenmeyer flask. The flask was rotated for 45 seconds and one volume of 
sterile phosphate buffered (0.03 M) triple distilled water containing 2.7% 
NaCl (pH 7.4, 22-25° C) was added to restore isotonicity. This preparation 
was transferred to 2 sterile silicone-treated 15 x 120 mm screw-cap tub~s 
and centrifuged at 200 x g for 10 minutes. 
The pelleted PMNS were resuspended and washed twice in approximately 
10 ml phosphate buffered (0.01 M) saline (PBS, pH 7.4, 22-25° C). The 
1
50% concentrate ACD: 
Citric Acid 
Sodium Citrate 
Dextrose 
Triple distilled water 
80 gm 
20 gm 
25 gm 
500 ml 
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cells were centrifuged at 200 x g for 10 minutes between each wash. After 
the second wash, the pelleted PMNS were resuspended in 0.8 ml bicarbonate 
. • ++ ++ 2 buffered (0.0268 M) Medium 199 without Ca and Mg (Ml99) • The cell 
viability, as determined by trypan blue staining, was a minimum of 95%. 
The cell suspension, as determined by Wright's stain, was 96-98% PMNS, 
2-4% erythrocytes, and less than 1% miscellaneous cells. 
2. Lymphocytes 
The lymphocyte-rich suspension was prepared by a modification of the 
method described by Boyum (71). Fifteen ml of whole blood containing ACD 
were diluted 1:3 in PBS (pH 7.4). Twenty ml of the diluted blood were 
carefully layered onto 8 ml Histopaque-10773 (22-25° C) in each of.2 sterile 
15 x 120 mm silicone-treated screw-cap tubes. 
The tubes were centrifuged at 400 x g for 45 minutes. The center milk-
like phase, containing the lymphocytes, was removed using a sterile 5 ml 
glass pipette with a pro-pipetter. The lymphocytes were transferred to a 
sterile silicone-treated tube and washed with bicarbonate buffered 
++ ++ 4 (0.0268 M) Hanks balanced salt solution without Ca and Mg (HBSS) . The 
ratio of HBSS to lymphocyte suspension was 3:1. After centrifugation at 
200 x g for 10 minutes, the supernatant was aseptically removed and the 
pelleted lymphocytes resuspended in 1 ml of Ml99 (22-25° C). The cell via-
bility, as determined by trypan blue staining, was a minimum of 97%. The 
cell suspension, as determined by Wright's stain, was 80-85% lymphocytes, 
2 
Gibco, Grand Island, NY (Lot Nos. 20N6210 and 18P7701). 
3 -~~- . Sigma, St. Louis, MO (Lot Nos. llF-6099 and 41F-6109). 
4 Gibco, Grand Island, NY (Lot Nos. 20Kl011 and C899305). 
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10-153 monocytes/macrophages, and 1-53 miscellaneous cells including eosin-
ophiles and basophiles. 
C. Antigen Production 
A Brucella whole cell antigen was prepared as described by Thoen et 
al. (72). Lyophilized .!!_. abortus strain 19 was reconstituted with sterile 
diluent. 5 Tryptose broth in 5 ml quantities was inoculated with 0.2 ml of 
the B. abortus solution and incubated for 72 hours at 37° C. Roux flasks 
containing tryptose agar were inoculated with 2 ml aliquots of the 72 hour 
broth cultures. After incubation at 37° C for 4 days, the cells were har-
vested by washing the agar surface with sterile PBS (pH 7.4). The PBS con-
taining the.!!_. abortus cells was autoclaved for 30 minutes at 121° C with 
17 p.s.i. and centrifuged for 45 minutes at 800 x g. After aseptic re-
moval of the supernatant, the cells were resuspended and washed once with 
approximately 20 ml sterile PBS (pH 7.4). The cells were resuspended in 3 
ml sterile PBS (pH 7.4); this concentrated antigen stock was stored at 
22-25° c. 
D. Concanavalin A Preparation 
Concanavalin A (Con A) from Conavalia ensformis (Jack beans) 6 was the 
mitogen used. Aliquots of stock solution containing 1 mg/ml in Ml99 were 
stored at -70° C. The stock was diluted and used the same day. 
E. Preparation of Agarose Plates 
Agarose plates were made daily. Each 60 x 15 mm plastic petri dish7 
5 N . 1 . . ationa Veterinary Services Laboratory, Ames, IA. 
·""- 6 .... '·Sigma, St. Louis, MO (Lot No. 79C:.7620). 
7 Falcon, Oxnard, CA. 
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contained a 5 ml mixture of agarose indubiose A45 8, 50% Ml99, and 10% heat-
inactivated serum. The agarose was dissolved in triple distilled water 
using a 100° C water bath and autoclaved for 5 minutes at 121° C and 17 
p.s.i. All components were equilibrated at 50° C before combining. The 
plates were incubated at 4° C for 1 hour; six 2.5 mm equidistant wells were 
cut in each plate using a sterile stainless steel punch and plexiglass tem-
plate. The agarose plugs were aseptically removed using a sterile Pasteur 
pipette connected to an aspirator. The plates were incubated at 37° C in a 
humidified atmosphere containing 5% co2 until used later that day. Immedi-
ately prior to use the wells were aseptically aspirated to remove any con-
densation. 
F. Leukocyte Migration Inhibition Assay Procedures 
The cells from each animal were divided into six test suspensions: 
1. PMNS (4 x 106 cells) 
2. PMNS with Brucella antigen 
3. PMNS with Con A 
4. PMNS (4 x 106) plus lymphocytes 6 (2 x 10 cells) 
5. PMNS plus lymphocytes with Brucella antigen 
6. PMNS plus lymphocytes with Con A 
The v/v ratio of cells to antigen/mitogen was 2:1; the suspensions 
that did not contain antigen or mitogen contained Ml99. The total volume 
of each suspension was 500 µl (200 µl PMNS, 200 µl lymphocytes, 100 µl 
antigen/mitogen). The suspensions were placed on a horizontal shaker for 
1 minute and incubated at 37° C in a humidified atmosphere containing 5% 
8 
Gallard-Schlesinger Chemical Mfg., Carle Place, NY (Pharmindustrie 
agarose Lot No. 3160). 
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2 CO for 1 hour. Each suspension (Nos. 1-6) was mixed on a vortex; then 
7 µl of each suspension were placed in each of 2 wells cut in agarose 
plates. The plates were incubated at 37° C in a humidified atmosphere con-
taining 5% co2 for 12 hours. 
G. Evaluation of Data 
After incubation, the plates were flooded with reagent grade methanol 
for 30 minutes (22-25° C). The methanol was poured off and 45% reagent 
grade formaldehyde added. After 30 minutes the formaldehyde and agarose 
were carefully removed. The cells fixed to the petri dish were stained 
for 15 minutes with 2% crystal violet. 
Two measurements of the diameter of cell migration were made at 90° 
angles to each other. Measurements (mm) were averaged and the area of 
migration was calculated Cn(l/2 diameter) 2). 
Percent migration (%M) was calculated as follows: 
= [area of migration of cells with mitogen minus area of well] %M 
area of cells without mitogen minus area of well 
Percent migration inhibition (%MI) was calculated as l00-%M. 
were statistically compared by analysis of variance. 
x 100 
Results 
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IV. EXAMINATION OF SOME VARIABLES IN A LEUKOCYTE MIGRATION 
INHIBITION ASSAY 
A. Serums Used to Supplement Cell Culture Media 
1. Serums from different animal species 
9 10 11 Heat-inactivated horse , fetal calf , and newborn calf serums were 
evaluated by comparing the areas of migration of PMN-rich suspensions col-
lected from 3 cows not exposed to!· abortus. Agarose plates containing 
0.83 agarose, 503 Ml99, and 103 of each respective serum were prepared. 
Cell suspensions from each of 3 cows were placed in duplicate wells cut in 
agarose plates. Three agarose plates containing each serum were used for 
each PMN sample. After incubation for 12 hours at 37° C in a humidified 
atmosphere containing 53 co2 the diameter of migration was measured and the 
area of migration calculated. The largest areas of migration were observed 
in plates containing newborn calf serum (mean= 78 mm2). The mean area of 
2 migration observed in plates containing· horse serum was 50 mm. The lowest 
areas of migration were observed in plates containing fetal calf serum 
(mean= 27 mm2). Newborn calf serum was selected as the media supplement. 
2. Comparison of different lots of newborn calf sera 
Six lots
12 
of heat-inactivated newborn calf sera were evaluated using 
PMN-rich suspensions prepared from 3 cows not exposed to B. abortus. Agar-
9 Gibco, Grand Island, NY (Lot No. 23K2002). 
10 Gibco, Grand Island, NY (Lot No. 19Pl131). 
11 
Gibco, Grand Island, NY (Lot No. 26P9301). 
12 Gibco, Grand Island, NY (Lot Nos. 20K9305, 24P9301, 25P9301, 26P9301, 
27Kl202 and 30N2902). 
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ose plates containing 0.8% agarose, 50% Ml99, and 10% of each respective 
lot of serum were prepared. Cell suspensions from each of 3 cows were 
placed in duplicate wells cut in agarose plates. Three agarose plates con-
taining each serum lot were used for each PMN sample. The plates were in-
cubated for 12 hours at 37° C in a humidified atmosphere containing 5% 
co
2
. The cells were fixed to the plates and the area of migration calcu-
lated. Results are shown in Table 1. 
Table 1. Area of migration (mean mm2) of PMNS obtained from 3 cows (Nos. 
1, 2 and 3) not exposed to B. abortus. Agarose plates contained 
0.8% agarose, 50% Ml99, and 10% of each respective lot (Nos. 
20K9305, 24P9301, 25P9301, 26P9301, 27Kl202 and 30N2902) of new-
born calf serum obtained from Gibco, Grand Island, NY 
Serum 
Lot number Cow No. 1 Cow No. 2 Cow No. 3 
20K9305 59.0 146.8 78.5 
24P9301 15.9 28.3 50.3 
25P9301 33.2 78.5 70.9 
26P9301 73.4 140.4 98.0 
27Kl202 <5 <5 <5 
30N2902 75.9 161.3 89.4 
PMN suspensions incubated in agarose plates containing Lot 27Kl202 did 
not migrate out of the wells. The greatest areas of migration (mean) of 
PMNS obtained from 2 of 3 cows (Nos. 1 and 2) were observed using plates 
containing Lot 30N2902; therefore, Lot 30N2902 was chosen to supplement 
cell culture media. 
B. Concentration of Agarose 
Three concentrations of agarose were evaluated using PMN-rich suspen-
sions obtained from 3 cows not exposed to B. abortus. Plates containing 
13 0.8%, 0.7%, or 0.6% agarose, 50% Ml99, and 10% newborn calf serum were 
13 
Gibco, Grand Island, NY (Lot No. 30N2902). 
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prepared. Duplicate wells in each plate were filled with each PMN suspen-
sion. Three plates containing each agarose concentration were used for 
each sample. The plates were incubated for 12 hours at 37P C in a humidi-
fied atmosphere containing 5% co2 • 
The plates containing 0.6% agarose were considered soft and unsuitable 
for use in the assay. In plates containing 0.7% agarose the areas of mi-
2 gration were 10-15 mm greater than in plates containing 0.8% agarose; 
therefore the concentration of agarose in the plates used for the duration 
of the study was 0.7%. 
C. Titration of Brucella Antigen 
Seven concentrations of a Brucella abortus whole cell antigen were 
evaluated. The antigen concentrations were equivalent to McFarland 
nephelometer tubes 3, 2, 1, and dilutions of tube 1 (1:4, 1:8, 1:16 and 
1:32). Lymphocyte and PMN suspensions from 2 cows (Nos. 26 and 36) from 
which B. abortus strain 2308 had been isolated, 2 cows (Nos. 1280 and 3746) 
vaccinated with~· abortus strain 19, and 1 cow (No. 3396) not exposed to 
B. abortus (control) were used. The cell suspensions contained 4 x 106 
6 PMNS and 2 x 10 lymphocytes in 400 µl. One hundred µl of antigen were 
added to cell suspensions and incubated at 37° C in 5% co
2 
for 1 hour. 
Control cell suspensions (no antigen) contained 100 µl of Ml99. Each cell 
suspension was placed in duplicate wells cut in agarose plates. The assay 
was performed in triplicate. The plates were incubated for 12 hours at 
37° C in a humidified atmosphere containing 5% co2 . The cells were fixed 
to the petri dish, stained, and the percent migration inhibition calculated. 
Results are shown in Table 2. 
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Table 2. Percent migration inhibition (mean) using PMNS plus lymphocytes 
obtained from 2 cows {Nos. 26 and 36) from which B. abortus 
strain 2308 was isolated, 2 cows (Nos. 1280 and 3746) vaccinated 
with B. abortus strain 19, and 1 cow (No. 3396) not exposed to 
B. abortus. PMNS plus lymphocytes were exposed to whole cell 
Brucella antigen concentrations equivalent to McFarland nephe-
lometer tubes 3, 2, 1 and dilutions of tube 1 (1:4, 1:8, 1:16 
and 1:32) 
Concentration of Brucella antigen 
Cow Mc3 Mc2 Mel Mel Mel Mel Mel 
number 1:4 1:8 1:16 1:32 
26 89.2 86.8 96.7 83.3 81.4 83.3 0.0 
36 79.9 75.0 84.0 64.0 72.4 66.9 0.0 
1280 87.7 86.6 78.2 81.2 87.8 85.3 72.0 
3746 94.0 96.0 96.0 84.0 87.8 79.8 0.0 
3396 14.0 13.8 13.8 7.0 7.0 3.4 0.0 
When cell suspensions were exposed to Brucella antigen at a 1:32 dilution 
of a McFarland nephelometer tube 1, the migration of PMNS plus lymphocytes 
(PMNS/L) obtained from both cows (Nos. 26 and 36) from which B. abortus was 
isolated and 1 of 2 cows (No. 3746) vaccinated with B. abortus strain 19 
was not inhibited. At a 1:8 or a 1:16 dilution of a McFarland nephelometer 
tube 1 the migration of PMNS/L from cows (Nos. 26, 36, 1280 and 3746) ex-
posed to ~- abortus was inhibited; the migration of PMNS/L from the cow 
(No. 3396) not exposed to~· abortus was not inhibited. The antigen con-
centration equivalent to a 1:8 dilution of a McFarland Nephelometer tube 1 
(O.D. = 0.055 at 525 nm) was chosen for use in the assay. Each time the 
antigen was used 0.5 ml of the suspension was placed on a blood agar plate 
and incubated for 48 hours at 37° C to evaluate for contamination. 
D. Titration of Concanavalin A 
The PMNS and lymphocytes from 1 cow (No. 54) from which B. abortus 
strain 2308 was isolated, 1 cow (No. 63) vaccinated with B. abortus strain 
19 
19, and 2 cows (Nos. 1329, 3396) not exposed to B. abortus (controls) were 
used to titrate Concanavalin A (Con A). Five concentrations of Con A 
(20 µg/ml, 10 µg/ml, 5 µg/ml, 3 µg/ml, and 2.5 µg/ml) were evaluated. One 
hundred µl of each Con A suspension were added to 400 µl containing 4 x 106 
PMNS plus 2 x 106 lymphocytes and incubated for 1 hour at 37° C with 5% 
co2 . Cell suspensions containing 100 µl of Ml99 instead of Con A were 
migration controls. Each suspension was placed in duplicate wells cut in 
plates containing 0.7% agarose, 50% Ml99, and 10% newborn calf serum. The 
assay was performed in triplicate. The plates were incubated for 12 hours 
at 37° C in a humidified atmosphere containing 5% co2 . Percent migration 
inhibition was calculated. Results are shown in Table 3. 
Table 3. Percent migration inhibition (mean) using PMNS plus lymphocytes 
obtained from 1 cow (No. 54) from which B. abortus strain 2308 
was isolated, 1 cow (No. 63) vaccinated with B. abortus strain 
Cow 
number 
54 
63 
1329 
3396 
19, and 2 cows (Nos. 1329 and 3396) not exposed to B. abortus. 
PMNS plus lymphocytes were exposed to 20 µg/ml, 10 µg/ml, 5 µg/ml, 
3 µg/ml or 2.5 µg/ml Concanavalin A. 
Concentration of Concanavalin A 
20 µg/ml 10 µg/ml 5 µg/ml 3 µg/ml 2.5 µg/ml 
64.0 62.5 57.4 57.4 0.0 
81.0 81.0 66.1 54.0 0.0 
91.2 91.2 71.9 75.0 0.0 
84.4 84.4 78.0 54.5 0.0 
A Con A concentration of 2.5 µg/ml did not inhibit the migration of 
PMNS plus lymphocytes. The concentration of 5 µg/ml inhibited the migra-
tion of PMNS plus lymphocytes obtained from all 4 cows and was selected for 
use in the assay. 
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E. Reproducibility of the Assay 
To examine the variability of results obtained in a leukocyte migra-
tion inhibition assay 200 ml of peripheral blood were asceptically col-
lected from each of 3 cows; !· abortus strain 2308 was isolated from 2 
cows (Nos. 53, 67), 1 cow (No. 3396) was not exposed to!· abortus. Fifty 
ml of blood were placed in each of 4 sterile silicone-treated 15 x 120 mm 
screw-cap tubes containing ACD. The 4 tubes of blood from each cow were 
randomly placed into two groups, A and B (2 tubes in each group). These 
groups were processed separately. The groups were identified as 53A, 53B, 
67A, 67B, 3396A, and 3396B. 
The PMNS and lymphocytes were harvested and the cell suspensions ex-
posed to a killed whole cell Brucella antigen or to Con A as previously de-
scribed. Cell suspensions from each group were placed in duplicate wells 
cut in agarose plates containing 0.7% agarose, 50% Ml99, and 10% newborn 
calf serum. After incubation for 12 hours at 37° C in a humidified atmo-
sphere containing 5% co2 , the percent migration inhibition was calculated. 
Results are shown in Graphs 1-3. 
The percents migration inhibition (%MI) of PMNS plus lymphocytes 
(PMNS/L) from groups 53A and 53B following incubation with a Brucella 
antigen were 61.5 and 55.6 respectively. The %MI of PMNS/L from groups 
53A and 53B following incubation with Con A were 37.1 and 30.6 respectively. 
The %MI was 55.6 for PMNS/L from each of groups 67A and 67B following incu-
bation with the antigen. The %MI was 30.6 for PMNS/L from each of groups 
67A and 67B following incubation with Con A. Although no differences were 
detected in the calculated %MI for PMNS/L from groups 67A and 67B,the areas 
Graph 1. Percent migration inhibition (mean) using PMNS/L obtained from 
groups 53A and 53B (B. abortus strain 2308 isolated) and incu-
bated with Brucella antigen (PMNS/L + Ag) or Con A (PMNS/L + Con A) 
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Graph 2. Percent migration inhibition (mean) using PMNS/L obtained from 
groups 67A and 67B (B. abortus strain 2308 isolated) and incubated 
with Brucella antigen (PMNS/L + Ag) or Con A (PMNS/L + Con A) 
24 
100 
90 
80 
'#. 
70 
• z 
0 -... 60 -Ill -::c 
z - 50 z 
0 ... 
<C 
a: 40 
(,!) -:e 
30 
20 
10 
A B A 
PMNS/L•Ag PMNS/L• Con A 
GROUP RESULTS FOR COW NO. 67 
Graph 3. Percent migration inhibition (mean) using·PMNS/L obtained from 
groups 3396A and 3396B (not exposed to B. abortus) and incubated 
with B~ucella antigen (PMNS/L + Ag) or Con A (PMNS/L + Con A) 
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of migration were different. The area of migration of PMNS/L from group 
67A not exposed to antigen or Con A was 86.6 mm2 ; the area of PMNS/L from 
·2 
group 67B not exposed to antigen or Con A was 113.1 mm • The %MI for 
PMNS/L from groups 3396A and 3396B following incubation with the antigen 
were 19.8 and 29.6 respectively. The %MI for PMNS/L from groups 3396A and 
3396B following incubation with Con A were 30.6 and 49.0 respectively. 
These findings provide evidence that suitable reproducibility was ob-
tained with the assay using Brucella antigen or Con A. 
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V. LEUKOCYTE MIGRATION INHIBITION ASSAY OF CELLS FROM COWS FROM WHICH 
BRUCELLA ABORTUS STRAIN 2308 WAS ISOLATED 
Blood was collected from each of 6 Charolais-Hereford cows (Nos. 26, 
40, 53, 54, 61 and 62) at 111, 114, 116, 119 and 121 days postexposure to 
2.98 x 107 colony forming units of B. abortus strain 2308 via the conjunc-
tival route (0.45 ml in each eye). B. abortus was isolated from the vagi-
nal discharge following parturition. 14 Two cows (Nos. 1329 and 3396) not 
exposed to~- abortus were included as controls. 
The pattern of migration of PMNS and PMNS plus lymphocytes from cow 
No. 53 (~. abortus was isolated) is shown in Figure 1. The average area of 
migration of PMNS from cows (Nos. 26, 40, 53, 54, 61 and 62) exposed to B. 
abortus strain 2308 was greater in cultures containing PMNS alone as com-
pared to cultures containing PMNS plus lymphocytes (average area of migra-
tion of PMNS was 98.6 mm2 ; average area of migration of PMNS plus lympho-
2 cytes was 80.7 mm). The migration of PMNS alone or the migration of PMNS 
plus lymphocytes (PMNS/L) was greater in cultures not containing Brucella 
antigen or Con A as compared to the migration of PMNS and PMNS/L in cul-
tures containing Brucella antigen or Con A. The %MI (group mean) was 
greater using cultures of PMNS/L incubated with Brucella antigen (62 ± 16) 
as compared to the %MI (group mean) using PMNS/L incubated with Con A 
(40 ± 24). 
The average area of migration of PMNS from cows (Nos. 1329 and 3396) 
not exposed to B. abortus was greater in cultures containing PMNS alone as 
14 Dr. Donald Pietz, U.S. Department of Agriculture, National 
Veterinary Services Laboratory, Ames, IA. 
Figure 1. Pattern of migration, under agarose, of PMNS (A) and PMNS/L (B) obtained from cow 
No. 53 from which B. abortus strain 2308 was isolated. The migration of PMNS (PMN) 
or PMNS/L (PMN M) not incubated with Brucella antigen or Concanavalin A and the 
migration of these cells following incubation with Brucella antigen (Ag) or Con-
canavalin A (Con A) are shown 
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compared to cultures containing PMNS/L (average area of migration of PMNS 
was 133 mm2 ; average area of migration of PMNS/L was 108 mm2). The migra-
tion of PMNS alone or the migration of PMNS/L was greater in cultures not 
containing Brucella antigen or Con A as compared to the migration of PMNS 
and PMNS/L in cultures containing Brucella antigen or Con A. The %Ml 
(group mean) was greater using cultures of PMNS/L incubated with Con A 
(33 ± 16) as compared to the %Ml (group mean) using PMNS/L incubated with 
Brucella antigen (15 ± 12). 
The %Ml using PMNS/L (group mean ± standard error) incubated with 
Brucella antigen or with Con A for two groups (6 cows from which B. abortus 
was isolated and 2 cows not exposed to .!· abortus) are shown in Graphs 4 
and 5 respectively. A significantly greater %Ml (mean) of PMNS/L was ob-
served for cows (Nos. 26, 40, 53, 54, 61, and 62) from which.!· abortus was 
isolated as compared to control cows (Nos. 1329 and 3396) when PMNS/L were 
incubated with Brucella antigen (p<0.002). When PMNS/L were incubated with 
Con A, no significant differences were observed between the two groups 
(p>0.05). 
The %MI using PMNS/L obtained from cows Nos. 26, 53, and 62 (_!. abortus 
was isolated) and incubated with Brucella antigen or with Con A are shown in 
Graphs 6, 7, and 8 respectively. The %MI using PMNS/L obtained from cow No. 
26 and incubated with Brucella antigen were 70.7, 57.2, 75.0 and 73.6 at 
114, 116, 119 and 121 days postexposure. The PMNS/L incubated with Con A 
had the following %Ml: 30.6, 14.8, 23.4 and 26.5 for the respective sample 
dates. The %MI using PMNS/L obtained from cow No. 53 and incubated with 
Brucella antigen were 65.1, 51.0, 44.8, 40.1 and 52.3 at 111, 114, 116, 119 
Graph 4. Percent migration inhibition (group mean ± standard error) using 
PMNS/L obtained from cows (Nos. 26, 40, 53, 54, 61 and 62) from 
which B. abortus strain 2308 was isolated (group 1) and from cows 
(Nos. l329 and 3396) not exposed to B. abortus (group 2). The 
PMNS/L were incubated with Bru~ella antigen 
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Graph 5. Percent migration inhibition (group mean ± standard error) using 
PMNS/L obtained from cows (Nos. 26, 40, 53, 54, 61 and 62) from 
which B. abortus strain 2308 was isolated (group 1) and from cows 
(Nos. l329 and 3396) not exposed to B. abortus (group 2). The 
PMNS/L were incubated with Con A -
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Graph 6. Percent migration inhibition 
at 114, 116, 119 and 121 day 
2308. The PMNS/L were incub 
Con A ( & ) 
1sing PMNS/L obtained from cow No. 26 
postexposure to B. abortus strain 
ted with Brucella-antigen ( • ) or 
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Graph 7. Percent migration inhibition using PMNS/L obtained from cow No. 53 
at 111, 114, 116, 119 and 121 days postexposure to B. abortus 
strain 2308. The PMNS/L were incubated with Brucella antigen ( • ) 
or Con A ( .A. ) 
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Graph 8. Percent migration inhibition using PMNS/L obtained from cow No. 62 
at 111, 114, 116 and 121 days postexposure to B. abortus strain 
2308. The PMNS/L were incubated with Brucella-antigen ( • ) or 
Con A ( A ) 
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and 121 days postexposure. The respective %MI obtained when PMNS/L were 
incubated with Con A were 40.3, 69.2, 26.5, 12.5 and 52.3. The %MI using 
PMNS/L obtained from cow No. 62 and incubated with Brucella antigen were 
66.0, 75.0, 85.5 and 40.0 at 111, 114, 116 and 121 days postexposure. The 
respective %MI obtained when PMNS/L were incubated with Con A were 16.0, 
60.9, 77.3 and 18.4. The %MI using PMNS/L obtained from cow No. 40 and in-
cubated with Brucella antigen were 52.7, 58.7 and 88.1 at 116, 119 and 121 
days postexposure. The respective %Ml obtained when PMNS/L were incubated 
with Con A were 80.9, 26.5 and 76.7. The %MI using PMNS/L obtained from 
cow No. 54 and incubated with Brucella antigen were 43.8 and 47.1 at 119 and 
121 days postexposure. The respective %MI obtained when PMNS/L were incu-
bated with Con A were 68.4 and 17.4. The %MI using PMNS/L obtained from 
cow No.61 and incubated with Brucella antigen was 88.0 at 119 days post-
exposure. The respective %MI obtained when PMNS/L were incubated with Con 
A was 21. 7. 
The %MI using PMNS/L obtained from cow No. 3396 (not exposed to!· 
abortus) and incubated with Brucella antigen or Con A are shown in Graph 9. 
The %MI using PMNS/L obtained from cow No. 3396 and incubated with Brucella 
antigen were 0.0, 18.4, 0.0 and 4.4 corresponding to 111, 114, 119 and 121 
days postexposure. The respective %MI obtained when PMNS/L were incubated 
with Con A were 54.1, 24.1, 14.2 and 21.0. The %MI using PMNS/L obtained 
from cow No. 1329 and incubated with Brucella antigen were 30.6, 18.1, 28.7 
and 18.4 corresponding to 114, 116, 119 and 121 days postexposure. The re-
spective %MI obtained when PMNS/L were incubated with Con A were 28.4, 48.5, 
21.0 and 51.4. 
Graph 9. Percent migration inhibition using PMNS/L obtained from cow No. 
3396 (not exposed to B. abortus) on dates corresponding to 111, 
114, 119 and. 121 days-postexposure to~· abortus s~rain 2308. 
The PMNS/L were incubated with Brucella antigen ( e ) or Con 
A ( A ) 
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VI. LEUKOCYTE MIGRATION INHIBITION ASSAY OF CELLS FROM COWS 
VACCINATED WITH BRUCELLA ABORTUS STRAIN 19 
Blood was collected from each of 2 Charolais-Hereford cows (Nos. 1280 
and 3746) at 116, 118, 121 and 123 days postvaccination. The cows were 
each vaccinated by. subcutaneous injection of 1.07 x 109 colony forming 
units of B. abortus strain 19. Two cows not exposed to B .• abortus descr1bed 
in Part V were included as controls. 
The average area of migration of PMNS obtained from cows (Nos. 1280 
and 3746) vaccinated with !· abortus strain 19 was greater in cultures con-
taining PMNS alone as compared to cultures containing PMNS plus lymphocytes 
2 (average area of migration of PMNS was 126.2 mm ; average area of migration 
2 of PMNS/L was 115.0 mm). The migration of PMNS alone or the migration of 
PMNS/L was greater in cultures not containing Brucella antigen or Con A as 
compared to the migration of PMNS or PMNS/L in cultures containing Brucella 
antigen or Con A. The %Ml (group mean) was greater using cultures of 
PMNS/L incubated with Brucella antigen (55 ± 23) as compared to the %Ml 
(group mean) using PMNS/L incubated with Con A (32 ± 24). 
The average area of migration of PMNS from cows (Nos. 1329 and 3396) 
not exposed to !· abortus was greater in cultures containing PMNS alone as 
compared to cultures containing PMNS/L (average area of migration of PMNS 
was 133 mm
2
-; average area of migration of PMNS/L was 108 mm2). The %Ml 
(group mean) was greater using cultures of PMNS/L incubated with Con A 
(33 ± 16) as compared to the %Ml (group mean) using PMNS/L incubated with 
Brucella antigen (15 ± 12). 
46 
The %MI using PMNS/L (group mean ± standard error) incubated with 
Brucella antigen or with Con A for two groups (2 cows vaccinated with B. 
abortus strain 19 and 2 cows not exposed to !· abortus) are shown in Graphs 
10 and 11. The %MI (group mean) was greater using PMNS/L obtained from 
cows (Nos. 1280 and 3746) vaccinated with B. abortus strain 19 as compared 
to PMNS/L obtained from cows (Nos. 1329 and 3396) when PMNS/L were incu-
bated with Brucella antigen (p<0.04). When PMNS/L were incubated with Con 
A,no significant differences were observed between the two groups (p>0.05). 
The %MI using PMNS/L obtained from cows Nos. 1280 and 3746 (vaccinated 
with !· abortus) and incubated with Brucella antigen or Con A are shown in 
Graphs 12 and 13. The %MI using PMNS/L obtained from cow No. 1280 and in-
cubated with Brucella antigen were 28.8, 37.3 and 36.7 at 118, 121 and 123 
days postvaccination. The PMNS/L incubated with Con A had the following 
%MI: 71.8, 16.0 and 33.1 for the respective sample dates. The %MI using 
PMNS/L obtained from cow No. 3746 and incubated with Brucella antigen were 
75.0, 78.9 and 70.8 at 116, 118 and 121 days postvaccination. The respec-
tive %MI using PMNS/L incubated with Con A were 10.0, 46.7 and 15.4. The 
%MI using PMNS/L obtained from cow No. 3396 (not exposed to!· abortus) 
and incubated wtth Brucella antigen or Con ·A are shown in Graph 14. The 
%MI using PMNS/L obtained from cow No. 3396 and incubated with Brucella 
antigen were 18.4, 0.0 and 4.4 corresponding to 116, 121 and 123 days post-
vaccination. The respective %MI using PMNS/L incubated with Con A were 
24.1, 14.2 and 21.0. The %MI using PMNS/L obtained from cow No. 1329 and 
incubated with Brucella antigen were 30.6, 18.1, 28. 7 and 18.4 correspond-·.>~--· 
ing to 116, 118, 121 and 123 days postvaccination. The respective %MI 
Graph 10. Percent migration inhibition (group mean ± standard error) using 
PMNS/L obtained from cows (Nos. 1280 and 3746) vaccinated with 
B. abortus strain 19 (group 1) and cows (Nos. 1329 and 3396) not 
exposed to B. abortus (group 2). The PMNS/L were incubated with 
Brucella antigen 
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Graph 11. Percent migration inhibition (group mean ± standard error) using 
PMNS/L obtained from cows (Nos. 1280 and 3746) vaccinated with 
B. abortus strain 19 (group l) and cows (Nos. 1329 and 3396) not 
exposed to B. abortus (group 2). The PMNS/L were incubated with 
Con A 
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Graph 12. Percent migration inhibition using PMNS/L obtained from cow No. 
1280 at 118, 121 and 123 days postvaccination with B. abortus 
strain 19. The PMNS/L were incubated with Brucella-antigen ( e) 
or Con A ( .& ) 
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Graph 13. Percent migration inhibition using PMNS/L obtained from cow No. 
3746 at 116, 118 and 121 days postvaccination with B. abortus 
strain 19. The PMNS/L were incubated with Brucella-antigen ( e ) 
or Con A ( & ) 
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Graph 14. Percent migration inhibition using PMNS/L obtained from cow No. 
3396 (not exposed to B. abortus) on dates corresponding to 116, 
121 and 123 days postvaccination with B. abortus strain 19. The 
PMNS/L were incubated with Brucella antigen ( e ) or Con A ( //J.. ) 
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using PMNS/L incubated with Con A were 28.4, 48.5, 21.0 and 51.4. 
The patterns of migration of PMNS/L obtained from cow No. 62 (!. 
abortus strain 2308 was isolated), cow No. 3746 (vaccinated with B. abortus 
strain 19) and cow No. 3396 (not exposed to B. abortus) are shown in 
Figure 2. 
The areas of migration (group means) of PMNS/L obtained from 2 cows 
(_Nos. 1329 and 3396) not exposed to !· abortus, 2 cows (Nos. 1280 and 3746) 
vaccinated with B. abortus strain 19, and 6 cows (Nos. 26, 40, 53, 54, 61 
and 62) from which B. abortus strain 2308 was isolated are shown in Graph 
15. A significantly greater area of migration (group mean) was observed 
for PMNS/L obtained from cows (Nos. 1329 and 3396) not exposed to Brucella 
abortus as compared to the area of migration of PMNS/L obtained from cows 
(Nos. 26, 40, 53, 54, 61 and 62) from which!· abortus strain 2308 was 
isolated (p<0.005). A greater area of migration (group mean) was observed 
using PMNS/L obtained from cows (Nos. 1280 and 3746) vaccinated with!· 
abortus strain 19 as compared to the area of migration of PMNS/L obtained 
from cows (Nos. 26, 40, 53, 54, 61 and 62) from which!· abortus was iso-
lated (p<0.01). 
The %MI (mean) for 3 groups (2 cows not exposed to!· abortus, 2 cows 
vaccinated with!· abortus strain 19, and 6_ cows from which B. abortus 
strain 2308 was isolated) using cultures of PMNS/L incubated with Brucella 
antigen are shown in Graph 16. The %MI (mean) for 3 groups using PMNS/L 
incubated with Con A are shown in Graph 17. 
Figure 2. Pattern of migration, under agarose, of PMNS/L obtained from cow No. 62 from which 
B. abortus strain 2308 was isolated (group 1), from cow No. 3746 vaccinated with 
B. abortus strain 19 (group 2), and from cow No. 3396 not exposed to B. abortus 
(group 3). The migration of PMNS/L (PMN M) not incubated with Brucella antigen or 
Concanavalin A and the migration of PMNS/L following incubation with Brucella 
antigen (Ag) or Concanavalin A (Con A) are shown 

Graph 15. Area of migration (mm2) of PMNS/L (group mean ± standard error) 
obtained from cows (Nos. 26, 40, 53, 54, 61 and 62) from which 
B. abortus strain 2308 was isolated (group 1), from cows (Nos. 
l280 and 3746) vaccinated with B. abortus strain 19 (group 2), 
and from cows (Nos. 1329 and 3396) not exposed to B. abortus 
(group 3) 
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Graph 16. Percent migration inhibition of PMNS/L (group mean ± standard 
error) obtained from cows (Nos. 26, 40, 53, 54, 61 and 62) from 
which B •. abortus strain 2308 was isolated (group 1), from cows 
(Nos. l28,0 and 3746) vaccinated with B. abortus strain 19 (group 
2), and from cows (Nos. 1329 and 3396) not exposed to B. abortus 
(group 3). The PMNS/L were incubated with Brucella antigen 
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Graph 17. Percent migration inhibition of PMNS/L (group mean± standard 
error) obtained from cows (Nos. 26, 40, 53, 54, 61 and 62) from 
which B. abortus strain 2308 was isolated (group 1), from cows 
(Nos. l280 and 3746) vaccinated with B. abortus strain 19 (group 
2), and from cows (Nos. 1329 and 3396) not exposed to B. abortus 
(group 3). The PMNS/L were incubated with Con A 
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VII. DISCUSSION 
An objective of this study was to examine some variables of a leuko-
cyte migration inhibition assay for detecting cell-mediated immune re-
sponses of cows exposed to~· abortus. The variables examined included: 
serum used to supplement cell culture media, concentration of agarose, 
titration of Brucella antigen and Con A. Reproducibility of the assay was 
also examined. 
Serum is used in cell culture media to maintain cellular viability 
and to support cellular proliferation in response to antigenic or mitogenic 
stimulation (73, 74). It has been reported that lymphocyte responsiveness 
varied when serums from various animal species and different lots of sera 
were examined (75, 76). Serum has been reported to stimulate, inhibit or 
kill lymphocytes (77, 78, 79, 80, 81 and 82). In this study, the areas of 
migration of PMNS obtained from cows not exposed to B. abortus differed 
when serums from various species and different lots of newborn calf sera 
were examined. The migration of PMNS (mean area) observed with fetal calf 
2 serum was 27 mm ; the migration of PMNS (mean area) observed with horse 
2 serum was 50 mm • The migration of PMNS· (mean area) observed with newborn 
calf serum was 78 mm2 . Considerable differences in the migration of PMNS 
obtained from cows not exposed to B. abortus were observed when different 
lots of newborn calf sera were used to supplement the cell culture media. 
2 The migration of PMNS (mean area) ranged from less than 5 mm (Lot 27Kl202) 
to 108.9 mm
2 
(Lot 30N2902). It is not known what contributed to the vari-
ability. However it has been suggested some serum.preparations contain 
67 
heat-stable factors with chemotactic properties; other preparations con-
taining high concentrations of albumin may inhibit PMN migration (83). 
These results illustrate the importance of examining different serums for 
use in a leukocyte migration inhibition assay. 
Various concentrations of agarose (ranging from 13 to 0.83) have been 
reported for use in leukocyte migration inhibition assays; however none of 
the reports indicate why a particular concentration was selected (12, 13, 
15, 70). To determine an optimum concentration of agarose for a bovine 
leukocyte migration inhibition assay, three concentrations of agarose (0.83, 
0.73 and 0.63) were examined. Greater migration (mean area) of PMNS ob-
tained from cows not exposed to !· abortus was observed in plates contain-
ing 0.73. agarose as compared to plates containing 0.83 agarose (10-15 mm2). 
Plates containing 0.63 agarose were too soft to provide suitable results. 
The area of migration of PMNS or PMNS/L in plates containing 0.73 agarose 
could be measured without using microscopy, eliminating the need for ex-
pensive microscopic or projection equipment used in some studies (12, 13, 
70). A possible explanation for the larger area of migration observed when 
a lower concentration of agarose was used may be that the matrix formed by 
the lower concentration of agarose had a larger pore size and less effect 
on the migration of cells as compared to the matrix formed by a higher con-
centration of agarose. 
It was observed that low concentrations of Con A (2.5 µg/ml) did not 
inhibit migration of PMNS/L obtained from cows exposed to !· abortus or 
obtained from cows not exposed to B. abortus; low concentrations of 
6B 
Brucella antigen (1:32 dilution of a McFarland nephelometer tube 1) did not 
inhibit migration of PMNS/L obtained from cows exposed to!· abortus or ob-
tained from cows not exposed to!· abortus. These results are in agreement 
with previous reports suggesting that the commitment of lymphocytes to 
activation was dependent on the concentration of antigen or Con A (B4). 
The concentration of Con A used in this study was 5 µg/ml; the concentra-
tion of Brucella antigen was equivalent to a l:B dilution of a McFarland 
nephelometer tube 1 (O.D. ~ 0.055 at 525 nm). 
Results reported in this study indicate that suitable assay reproduc-
ibility was obtained when duplicate samples from cows were processed simul-
taneously. However samples collected from the same cow on different sample 
dates provided variable results. Variability of response for different 
sample dates has been reported previously (13, 15, B5, B6). A variety of 
in vivo factors including low molecular weight inhibitors, monosaccharides, 
immunoglobulins, ketone bodies, corticosteroids and transfer factor have 
been reported to influence responses of lymphocytes and PMNS measured in 
vitro, including PMNS/L migration (B7, BB, B9, 90, 91, 92, 93, 94). It 
should be emphasized that the in vivo concentrations of these factors may 
vary on different sample dates thereby influencing the responses measured 
in vitro (BB, 90, ·93, 94). 
A second objective of this study was to examine the applicability of 
the assay for detecting and differentiating cellular responses of cattle 
following exposure to virulent !· abortus strain 230B or to attenuated B. 
abortus strain 19. The importance of comparing experimental groups direct-
ly to contro'l groups without using arbitrary values to distinguish positive 
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from negative results has been emphasized (11). A significantly greater 
%MI (group mean) was observed using PMNS/L obtained from cows (Nos. 26, 40, 
53, 54, 61 and 62) from which B. abortus strain 2308 was isolated as com-
pared to using PMNS/L obtained from ·cows (Nos. 1329 and 3396) not exposed 
to B. abortus when PMNS/L were incubated with Brucella antigen (p<0.002). 
The %MI (group mean) was greater using PMNS/L obtained from cows (Nos. 1280 
and 3746) vaccinated with B. abortus strain 19 as compared to the %MI using 
PMNS/L obtained from cows (Nos. 1329 and 3396) not exposed to B. abortus 
when PMNS/L were incubated with Brucella antigen (p<0.04). These results 
indicate that a leukocyte migration inhibition assay as described herein 
using Brucella antigen may be useful in differentiating responses of cows 
infected with B. abortus strain 2308 or cows vaccinated as adults with B. 
abortus strain 19 from cows not exposed to B. abortus. Responses of PMNS/L; 
following incubation with Con A, obtained from cows from which B. abortus 
strain 2308 was isolated, cows vaccinated with~- abortus strain 19, and 
cows not exposed to B. abortus were not significantly different (p>0.05). 
Significant differences were observed when the area of migration of 
PMNS/L obtained from cows from which B. abortus strain 2308 was isolated 
was compared to the area of migration of PMNS/L obtained from cows vacci-
nated with B. abortus strain 19 (p<0.01) or was compared to the area of 
migration of PMNS/L obtained from cows not exposed to B. abortus (p<0.005). 
However, bovine PMNS have been reported to have large differences in their 
ability to migrate; therefore, it is possible the differences observed in 
the areas of m"tgration are not related to exposure to~- abortus (86). No 
significant difference was observed when %MI (group mean) of PMNS/L 
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obtained from cows (Nos. 26, 40, 53, 54, 61 and 62) from which B. abortus 
strain 2308 was isolated was compared to %MI (group mean) of PMNS/L ob-
tained from cows (Nos. 1280 and 3746) vaccinated with B. abortus strain 19 
when PMNS/L were incubated with Brucella antigen (p>0.05). These results 
indicate that cellular responses of cows exposed to B. abortus strain 2308 
and responses of cows vaccinated as adults with B. abortus strain 19 ob-
served in a leukocyte migration inhibition assay using Brucella antigen 
were not different. 
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VIII. SUMMARY 
Some variables affecting a leukocyte migration inhibition assay for 
detecting cell-mediated immune responses of cows exposed to !· abortus were 
examined. It was observed that areas of migration of PMNS obtained from 
cows not exposed to !· abortus were greater (78 mm2) when newborn calf 
serum was used to supplement cell culture media as compared to the areas of 
migration of PMNS when either horse serum (50 mm2 ) or fetal calf serum 
(27 mm2) were used. Considerable differences in the migration of PMNS ob-
tained from cows not exposed to !· abortus were observed when different 
lots of newborn calf sera were used to supplement cell culture media (range 
2 2 <5 mm to 108.9 mm). To determine an optimum concentration of agarose for 
a bovine leukocyte migration inhibition assay, three concentrations of aga-
rose (0.6%, 0.7% and 0.8%) were examined. Greater migration (mean area) of 
PMNS obtained from cows not exposed to B. abortus was observed in plates 
containing 0.7% agarose as compared to plates containing 0.8% agarose 
(10-15 mm2). Plates containing 0.6% agarose were too soft to provide suit-
able results. Low concentrations of Con A (2.5 µg/ml) did not inhibit mi-
gration of PMNS plus lymphocytes (PMNS/L) obtained from cows exppsed to !· 
abortus or cows not exposed to !· abortus; low con.centrations of Brucella 
antigen (1:32 dilution of a McFarland nephelometer tube 1) did not inhibit 
migration of PMNS/L obtalned from cows exposed to B. abortus strain 2308 or 
to B. abortus strain 19. The concentration of Con A used in this study was 
5 µg/ml; the concentration of Brucella antigen was equivalent to a 1:8 
dilution of a McFarland nephelometer tube 1 (O.D. = 0.055 at 525 nm). 
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Suitable assay reproducibility was obtained when duplicate samples were 
processed simultaneously. 
Applicability of the assay for detecting and differentiating cellular 
responses of cows following exposure to virulent B. abortus strain 2308 or 
to attenuated B. abortus strain 19 was examined. Significantly greater 
percent migration inhibition (%MI) was observed using (PMNS/L) from cows 
from which B. abortus strain 2308 was isolated as compared to %MI using 
PMNS/L obtained from cows not exposed to B. abortus when PMNS/L were incu-
bated with Brucella antigen (p<0.002). The %MI was greater using PMNS/L 
obtained from cows vaccinated with!· abortus strain 19 as compared to the 
%MI using PMNS/L obtained from cows not exposed to B. abortus when PMNS/L 
were incubated with Brucella antigen (p<0.04). Responses of PMNS/L, follow-
ing incubation with Con A, obtained from cow~ from which!· abortus strain 
2308 was isolated, cows vaccinated with!· abortus strain 19, and cows not 
exposed to!· abortus were not significantly different (p<0.05). Signifi-
cant differences were observed when area of migration of PMNS/L obtained 
from cows from which B. abortus strain 2308 was isolated was compared to 
area of migration of PMNS/L obtained from cows vaccinated with !· abortus 
strain 19 (p<0.01) or was compared to area of migration of PMNS/L obtained 
from cows not exposed to B. abortus (p<0.005). No significant differences 
were observed when %MI using PMNS/L obtained from cows from which B. 
abortus strain 2308 was isolated was compared to %MI using PMNS/L obtained 
from cows vaccinated with B. abortus strain 19 when PMNS/L were incubated 
with Brucella antigen (p>0.05). 
1. 
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